Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AdaptHealth (AHCO) EBITDA Margin (2019 - 2025)

Historic EBITDA Margin for AdaptHealth (AHCO) over the last 7 years, with Q3 2025 value amounting to 18.81%.

  • AdaptHealth's EBITDA Margin rose 3600.0% to 18.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.92%, marking a year-over-year increase of 99300.0%. This contributed to the annual value of 18.61% for FY2024, which is 263600.0% up from last year.
  • Per AdaptHealth's latest filing, its EBITDA Margin stood at 18.81% for Q3 2025, which was up 3600.0% from 20.8% recorded in Q2 2025.
  • AdaptHealth's 5-year EBITDA Margin high stood at 21.32% for Q4 2024, and its period low was 46.11% during Q3 2023.
  • For the 5-year period, AdaptHealth's EBITDA Margin averaged around 12.46%, with its median value being 17.67% (2022).
  • Its EBITDA Margin has fluctuated over the past 5 years, first plummeted by -640000bps in 2023, then soared by 645600bps in 2024.
  • Over the past 5 years, AdaptHealth's EBITDA Margin (Quarter) stood at 19.1% in 2021, then decreased by -20bps to 15.25% in 2022, then plummeted by -200bps to 15.26% in 2023, then surged by 240bps to 21.32% in 2024, then decreased by -12bps to 18.81% in 2025.
  • Its EBITDA Margin stands at 18.81% for Q3 2025, versus 20.8% for Q2 2025 and 14.45% for Q1 2025.